$7.43
-0.22 (-2.88%)
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.
RSS Headlines
Fool UK